Varenne Capital Partners
Latest statistics and disclosures from Varenne Capital Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are UBS, Qiagen Nv, Activision Blizzard, Horizon Therapeutics, National Instruments, and represent 98.94% of Varenne Capital Partners's stock portfolio.
- Added to shares of these 6 stocks: Activision Blizzard (+$10M), UBS (+$9.1M), National Instruments, Horizon Therapeutics, FTRE, Heritage-Crystal Clean.
- Started 3 new stock positions in FTRE, National Instruments, Heritage-Crystal Clean.
- Reduced shares in these 7 stocks: SBUX (-$136M), CTVA (-$22M), Univar (-$5.3M), Arconic, LCW, PEGR, Corsair Partnering Corp A.
- Sold out of its positions in Arconic, CTVA, SBUX, Univar, Corsair Partnering Corp A, PEGR.
- Varenne Capital Partners was a net seller of stock by $-140M.
- Varenne Capital Partners has $104M in assets under management (AUM), dropping by -51.76%.
- Central Index Key (CIK): 0001902567
Tip: Access up to 7 years of quarterly data
Positions held by Varenne Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Varenne Capital Partners
Varenne Capital Partners holds 8 positions in its portfolio as reported in the September 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Ubs Group Call Call Option (UBS) | 44.9 | $47M | +24% | 491k | 94.77 |
|
Qiagen Nv Shs New | 23.7 | $25M | 607k | 40.51 |
|
|
Activision Blizzard | 19.0 | $20M | +105% | 210k | 93.63 |
|
Horizon Therapeutics Pub L SHS | 7.8 | $8.1M | +23% | 70k | 115.69 |
|
National Instruments | 3.5 | $3.6M | NEW | 61k | 59.62 |
|
Fortrea Hldgs Common Stock (FTRE) | 0.6 | $660k | NEW | 23k | 28.59 |
|
Heritage-Crystal Clean | 0.4 | $419k | NEW | 9.2k | 45.35 |
|
Learn Cw Investment Cor Cl A Ord Shs (LCW) | 0.0 | $17k | -24% | 1.6k | 10.66 |
|
Past Filings by Varenne Capital Partners
SEC 13F filings are viewable for Varenne Capital Partners going back to 2021
- Varenne Capital Partners 2023 Q2 restated filed Nov. 14, 2023
- Varenne Capital Partners 2023 Q3 filed Nov. 14, 2023
- Varenne Capital Partners 2023 Q2 filed Aug. 11, 2023
- Varenne Capital Partners 2023 Q1 filed May 12, 2023
- Varenne Capital Partners 2022 Q4 filed Feb. 13, 2023
- Varenne Capital Partners 2022 Q3 filed Nov. 9, 2022
- Varenne Capital Partners 2022 Q2 filed July 27, 2022
- Varenne Capital Partners 2022 Q1 filed May 12, 2022
- Varenne Capital Partners 2021 Q4 filed Feb. 14, 2022